Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine in patients undergoing methadone maintenance treatment
IRCT20250305064941N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in substance use disorder (SUD) comparing Quetiapine with Placebo (2 arms). Primary endpoints: Craving, Heart rate and 1 more. Started Apr 2025; status: completed.
02
Drugs
quetiapine
03
Conditions
substance use disorder (SUD)
Beyond the preview
Go deeper on IRCT20250305064941N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250305064941N1.